<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04968197</url>
  </required_header>
  <id_info>
    <org_study_id>21-005284</org_study_id>
    <nct_id>NCT04968197</nct_id>
  </id_info>
  <brief_title>Vestibular Intervention Via Portable Electrical Stimulator (VIPES)</brief_title>
  <official_title>Vestibular Intervention Via Portable Electrical Stimulator (VIPES)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to develop a vestibular interventional approach using stochastic&#xD;
      vestibular stimulation (SVS) through a small, lightweight device, and a comfortable electrode&#xD;
      set on the back of the head that stimulates the vestibular system and produces immediate&#xD;
      improvements in balance, gait, and overall vestibular function for patients will balance&#xD;
      disorder.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2022</start_date>
  <completion_date type="Anticipated">August 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in balance performance</measure>
    <time_frame>Through study completion, approximately 1.5 hours</time_frame>
    <description>Change in balance performance during balance testing by measuring sway score across tested levels of GVR amplitude and control condition.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Balance Disorder</condition>
  <arm_group>
    <arm_group_label>Stochastic Vestibular Stimulation (SVS) Condition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will perform standard clinical testing for balance and gait while wearing the Vestibular Intervention via Portable Electrical Stimulator (VIPES) system. The SVS device will be active throughout the testing at the respective current levels (i.e., 0.2mA to 1 mA at 0.2 mA increments).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Condition</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects will perform standard clinical testing for balance and gait without SVS</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vestibular Intervention via Portable Electrical Stimulator (VIPES) system</intervention_name>
    <description>A small, lightweight device able to deliver stochastic vestibular stimulation (SVS) using a comfortable electrode set on the back of the head as well as other proven modes of galvanic vestibular stimulation (GVS) related vestibular correction when required to mitigate motion sickness or provide auxiliary vestibular cueing.</description>
    <arm_group_label>Stochastic Vestibular Stimulation (SVS) Condition</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participants must be able to consent to participate themselves.&#xD;
&#xD;
          -  Participants must be 21 to 55 years of age.&#xD;
&#xD;
          -  Must be able to attend in-person sessions at the Mayo Aerospace Medicine and -&#xD;
             Vestibular Research Laboratory in Scottsdale, AZ.&#xD;
&#xD;
          -  No racial/ethnic groups will be excluded.&#xD;
&#xD;
          -  All participants must be fluent speakers of English.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of peripheral vestibulopathy (cleared by Dix-Hallpike, vHIT as part of&#xD;
             clinical evaluation).&#xD;
&#xD;
          -  Women who are pregnant.&#xD;
&#xD;
          -  Inability to complete testing (e.g., severe symptom burden, inability to stand&#xD;
             unassisted).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gaurav N Pradhan</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Arizona</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 7, 2021</study_first_submitted>
  <study_first_submitted_qc>July 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 20, 2021</study_first_posted>
  <last_update_submitted>October 12, 2021</last_update_submitted>
  <last_update_submitted_qc>October 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Gaurav N. Pradhan</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

